Welcome to LookChem.com Sign In|Join Free

CAS

  • or

111223-26-8

Post Buying Request

111223-26-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

111223-26-8 Usage

Uses

Antihypertensive.

Check Digit Verification of cas no

The CAS Registry Mumber 111223-26-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,1,2,2 and 3 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 111223-26:
(8*1)+(7*1)+(6*1)+(5*2)+(4*2)+(3*3)+(2*2)+(1*6)=58
58 % 10 = 8
So 111223-26-8 is a valid CAS Registry Number.
InChI:InChI=1/C21H33N2O6P/c22-14-6-4-13-19(20(24)23-15-8-12-18(23)21(25)26)29-30(27,28)16-7-5-11-17-9-2-1-3-10-17/h1-3,9-10,18-19H,4-8,11-16,22H2,(H,25,26)(H,27,28)/t18-,19-/m0/s1

111223-26-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-[6-amino-2-[hydroxy(4-phenylbutyl)phosphoryl]oxyhexanoyl]pyrrolidine-2-carboxylic acid

1.2 Other means of identification

Product number -
Other names Ceranapril

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:111223-26-8 SDS

111223-26-8Downstream Products

111223-26-8Related news

Determination of parts per million levels of trifluoroacetic acid in Ceronapril (cas 111223-26-8) bulk substance by headspace capillary gas chromatography09/02/2019

A headspace capillary gas chromatographic method was developed to determine trifluoroacetic acid (TFA) in a bulk substance (ceronapril). The bulk sample is reacted in a sealed headspace vial with dimethyl sulfate in concentrated sulfuric acid to convert TFA to methyl trifluoroacetate (MTFA). A p...detailed

Research paperUptake and transport of the ACE-inhibitor Ceronapril (cas 111223-26-8) (SQ 29852) by monolayers of human intestinal absorptive (Caco-2) cells in vitro09/01/2019

The angiotensin-converting enzyme (ACE)-inhibitor ceronapril (SQ 29852) is shown to be a substrate of the intestinal dipeptide transporter. Uptake by Caco-2 cells, grown as confluent monolayers, follows a major saturable pathway (Km, 0.91 ± 0.11 mM; ∼90% at 1 mM) together with a minor passive ...detailed

Effect of acute and chronic administration of Ceronapril (cas 111223-26-8) on angiotensin converting enzyme in plasma, kidney, lung, brain regions and cerebrospinal fluid of rats08/31/2019

Angiotensin converting enzyme (ACE) in brain, cerebrospinal fluid (C.S.F.) and peripheral tissues was studied ex vivo after oral administration of ceronapril (SQ 29,852) to male Sprague-Dawley rats. Angiotensin converting enzyme in tissue was measured by in vitro autoradiography or enzymatic ass...detailed

A neuroleptic-like effect of Ceronapril (cas 111223-26-8) on latent inhibition08/30/2019

Three experiments that used a latent inhibition procedure to investigate the effects of ceronapril on attentional processes in the rat are reported. Latent inhibition is a behavioural paradigm in which prior exposure to a stimulus with no significant consequences retards subsequent conditioning ...detailed

Effects of Ceronapril (cas 111223-26-8) alone or in combination with alcohol on psychomotor performance in healthy volunteers: a placebo-controlled, crossover study08/29/2019

Background: Behavioral evidence from animal studies has suggested that ceronapril and other angiotensin-converting enzyme (ACE) inhibitors have some anxiolytic activity.Objectives: The objectives of this trial were to assess the effects of ceronapril, a centrally acting ACE inhibitor, on psychom...detailed

111223-26-8Relevant articles and documents

(Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme (ACE). 1. Discovery of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]- -proline, a novel orally active inhibitor of ACE

Karanewsky,Badia,Cushman,DeForrest,Dejneka,Loots,Perri,Petrillo Jr.,Powell

, p. 204 - 212 (2007/10/02)

The synthesis of a series of orally active, phosphinyloxyacyl proline inhibitors of angiotensin converting enzyme (ACE) is described. The in vitro and in vivo ACE inhibitory activities are reported for each compound. The structure-activity relationship fo

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 111223-26-8